-
公开(公告)号:US12024509B2
公开(公告)日:2024-07-02
申请号:US16814328
申请日:2020-03-10
IPC分类号: C07D471/04 , A61K31/4192 , A61K31/435 , A61K31/4439 , A61K31/47 , A61P3/04 , A61P19/10 , A61P25/00 , A61P25/04 , A61P25/06 , A61P25/14 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P25/30 , A61P25/32 , A61P25/34 , A61P25/36 , A61P43/00 , C07C233/69 , C07C233/78 , C07C275/28 , C07C275/40 , C07D213/63 , C07D213/64 , C07D213/74 , C07D231/38 , C07D235/26 , C07D235/30 , C07D239/34 , C07D239/42 , C07D239/80 , C07D239/84 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/12 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14
CPC分类号: C07D471/04 , C07C233/69 , C07C233/78 , C07C275/28 , C07C275/40 , C07D213/63 , C07D213/64 , C07D213/74 , C07D231/38 , C07D235/26 , C07D235/30 , C07D239/34 , C07D239/42 , C07D239/80 , C07D239/84 , C07D401/12 , C07D401/14 , C07D403/12 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14
摘要: The present invention relates to compounds that are inhibitors of the orexin-1 receptor. The compounds have the structural formula I defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or disorders associated with orexin-1 receptor activity.
-
2.
公开(公告)号:US20230180761A1
公开(公告)日:2023-06-15
申请号:US18166601
申请日:2023-02-09
发明人: RONALD J. HEEMSTRA , RONALD ROSS, JR. , KYLE A. DEKORVER , KAITLYN GRAY , DANIEL I. KNUEPPEL , PETER VEDNOR , TIMOTHY P. MARTIN , JOSEPH D. ECKELBARGER , JOHN F. DAEUBLE, SR. , RICKY HUNTER , DAVID A. DEMETER , TONY K. TRULLINGER , ERICH W. BAUM , ZOLTAN L. BENKO , NAKYEN CHOY , GARY D. CROUSE , FANGZHENG LI , JEFFREY NISSEN , MONICA B. OLSON , MICHELLE RIENER , THOMAS C. SPARKS , FRANK J. WESSELS , MAURICE C. YAP
IPC分类号: A01N53/00 , C07C255/46 , C07C255/57 , C07C255/60 , C07C259/10 , C07D213/84 , C07D213/89 , C07D215/227 , C07C271/28 , C07C271/66 , C07D215/38 , C07D231/56 , C07D233/36 , C07C311/08 , C07C311/46 , C07D235/30 , C07C317/28 , C07C317/40 , C07C317/50 , C07C323/41 , C07C323/42 , C07C323/59 , C07C331/12 , C07C381/10 , C07D205/04 , C07C237/42 , C07D207/452 , C07C255/29 , C07D209/49 , C07D213/75 , C07D213/81 , C07D309/14 , C07D231/12 , C07D331/04 , C07D333/36 , C07D249/08 , C07D207/10 , C07D285/06 , C07D295/32 , C07D305/08 , C07D207/273 , C07D233/80 , C07D261/12 , C07D263/26 , C07D277/36 , C07D307/33 , C07D333/48 , C07C237/22 , C07D213/56 , C07D277/30 , C07D307/52 , C07D333/60 , A01N37/22 , A01N37/34 , A01N41/10 , A01N43/40 , A01N43/60 , A01N43/653 , A01N43/707 , A01N43/82 , A01N43/90 , C07C233/63 , C07C233/65 , C07C317/14 , C07D241/20 , C07D253/07 , C07D487/04
CPC分类号: A01N53/00 , C07C255/46 , C07C255/57 , C07C255/60 , C07C259/10 , C07D213/84 , C07D213/89 , C07D215/227 , C07C271/28 , C07C271/66 , C07D215/38 , C07D231/56 , C07D233/36 , C07C311/08 , C07C311/46 , C07D235/30 , C07C317/28 , C07C317/40 , C07C317/50 , C07C323/41 , C07C323/42 , C07C323/59 , C07C331/12 , C07C381/10 , C07D205/04 , C07C237/42 , C07D207/452 , C07C255/29 , C07D209/49 , C07D213/75 , C07D213/81 , C07D309/14 , C07D231/12 , C07D331/04 , C07D333/36 , C07D249/08 , C07D207/10 , C07D285/06 , C07D295/32 , C07D305/08 , C07D207/273 , C07D233/80 , C07D261/12 , C07D263/26 , C07D277/36 , C07D307/33 , C07D333/48 , C07C237/22 , C07D213/56 , C07D277/30 , C07D307/52 , C07D333/60 , A01N37/22 , A01N37/34 , A01N41/10 , A01N43/40 , A01N43/60 , A01N43/653 , A01N43/707 , A01N43/82 , A01N43/90 , C07C233/63 , C07C233/65 , C07C317/14 , C07D241/20 , C07D253/07 , C07D487/04 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/14
摘要: This disclosure relates to the field of molecules having pesticidal utility against pests in Phyla Arthropoda, Mollusca, and Nematoda, processes to produce such molecules, intermediates used in such processes, pesticidal compositions containing such molecules, and processes of using such pesticidal compositions against such pests. These pesticidal compositions may be used, for example, as acaricides, insecticides, miticides, molluscicides, and nematicides. This document discloses molecules having the following formula (“Formula One”).
-
公开(公告)号:US20230122024A1
公开(公告)日:2023-04-20
申请号:US17971547
申请日:2022-10-21
发明人: Jef De Brabander , Daniel Rosenbaum , Qiren Liang , Wentian Wang
IPC分类号: C07D491/107 , C07D235/30 , C07D401/06 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/06 , C07D413/06 , C07D413/12 , C07D417/12 , C07D471/04 , A61K31/428 , A61K31/4192 , A61K31/427 , A61K31/4439 , A61K31/422 , A61K31/4355 , A61K31/4709 , A61K31/4184 , A61K31/501 , A61K31/506 , A61K31/423
摘要: Methods and compositions for agonizing a type-2 orexin receptor (OX2R) in a cell determined to be in need thereof, including the general method of (a) administering to a subject a cyclic guanidinyl OX2R agonist and (b) detecting a resultant enhanced wakefulness or increased resistance to diet-induced accumulation of body fat, or abbreviated recovery from general anesthesia or jet lag.
-
公开(公告)号:US20220402880A1
公开(公告)日:2022-12-22
申请号:US17753980
申请日:2020-09-23
发明人: Nilesh ZAWARE , Ming-Ming ZHOU , Chunyan REN , Claudia KIM , Sudeh IZADMEHR , Matthew GALSKY
IPC分类号: C07D235/30 , C07D209/08 , C07D403/06 , A61P35/00
摘要: A genus of bicyclic inhibitors of CBX chromodomains is disclosed. The compounds are of the following genus: The compounds inhibit CBX proteins and, as a consequence, they are useful for treating prostate cancer, ovarian cancer, and B-cell lymphoma.
-
公开(公告)号:US11453647B2
公开(公告)日:2022-09-27
申请号:US16640490
申请日:2018-08-20
申请人: Merck Patent GmbH
发明人: Eva-Maria Tanzer , Kai Schiemann , Markus Klein
IPC分类号: C07D235/30 , A61P35/04 , C07D401/12 , C07D403/04 , C07D403/10 , C07D403/12 , C07D405/04 , C07D405/14 , C07D413/04 , C07D413/14 , C07D417/14 , C07D471/04 , C07D471/10 , C07D491/048 , C07D491/052 , C07D491/107 , C07D491/113 , C07D498/10 , A61K45/06
摘要: The invention relates to benzimidazole derivatives of the general formula I, and the use of the compounds of the present invention for the treatment and/or prevention of hyperproliferative or infectious diseases and disorders in mammals, especially humans, and pharmaceutical compositions containing such compound.
-
6.
公开(公告)号:US20220169641A1
公开(公告)日:2022-06-02
申请号:US17399338
申请日:2021-08-11
申请人: vTv Therapeutics LLC
发明人: Adnan M.M. Mjalli , Dharma Rao Polisetti , Jareer Nabeel Kassis , Matthew J. Kostura , Mustafa Guzel , Otis Clinton Attucks , Robert Carl Andrews , Samuel Victory , Suparna Gupta
IPC分类号: C07D417/12 , C07D417/14 , C07D471/04 , A61P1/16 , A61K31/4168 , A61K31/4188 , A61K31/428 , A61K31/437 , C07D235/30 , C07D513/04
摘要: Substituted fused imidazole derivatives, methods of their preparation, pharmaceutical compositions comprising a substituted fused imidazole derivative, and methods of use in treating renal diseases are provided. The substituted fused imidazole derivatives may control the activity or the amount or both the activity and the amount of heme-oxygenase.
-
公开(公告)号:US20220000118A1
公开(公告)日:2022-01-06
申请号:US16492722
申请日:2018-03-08
IPC分类号: A01N47/30 , C07D233/88 , C07D405/12 , C07D409/12 , C07D401/12 , C07D235/30 , C07D403/12 , A61K31/4168 , A61K31/5377 , A61K31/4178 , A61K31/4439 , A61K31/4184 , A01P1/00 , A61P31/04 , A01N47/36 , A01N47/32 , C09D5/14 , A61L2/232
摘要: Provided are 2-aminoimidazole-phenyl derivative compounds of Formula (I): which compounds are useful in methods of controlling microbial growth, such as by enhancing the effects of an antibiotic administered in combination with the compound. Compositions including these compounds, devices including these compounds, and methods of using the same are also provided.
-
公开(公告)号:US11098018B2
公开(公告)日:2021-08-24
申请号:US16638590
申请日:2018-08-13
申请人: ACESION PHARMA ApS
发明人: Ulrik Svane Sørensen , Antonio Mete
IPC分类号: C07D235/30
摘要: A compound of the general formula (I). The compounds of formula I are useful for treatment of a cardiac disease, disorder or condition in a mammal.
-
公开(公告)号:US20210206728A1
公开(公告)日:2021-07-08
申请号:US17254890
申请日:2019-06-26
发明人: Dahai WANG , Wenyuan QIAN , Shilan LIU , Shuhui CHEN
IPC分类号: C07D235/30
摘要: The present invention relates to benzimidazole compounds and an application thereof as IDH1 mutant inhibitors, in particular, to a compound as represented by formula (I), tautomers thereof, or pharmaceutically acceptable salts thereof.
-
公开(公告)号:US20210188804A1
公开(公告)日:2021-06-24
申请号:US16078128
申请日:2017-02-23
申请人: ACESION PHARMA ApS
发明人: Ulrik Svane SØRENSEN , Antonio METE
IPC分类号: C07D401/12 , C07D235/30 , C07D405/12 , C07D403/12 , C07D413/12 , C07D491/107 , C07D417/12
摘要: The present invention relates to a compound of the general formula (I). The compounds of formula I are useful for treatment of a cardiac disease, disorder or condition in a mammal.
-
-
-
-
-
-
-
-
-